Amy Araucto is a highly motivated sales professional with over 15 years of pharmaceutical sales excellence, currently serving as the Regional Field Sales Trainer for Advanced Accelerator Applications. In this pivotal role, Amy is instrumental in the launch and promotion of Pluvicto, a groundbreaking radioligand...
Amy Araucto is a highly motivated sales professional with over 15 years of pharmaceutical sales excellence, currently serving as the Regional Field Sales Trainer for Advanced Accelerator Applications. In this pivotal role, Amy is instrumental in the launch and promotion of Pluvicto, a groundbreaking radioligand therapy specifically designed for advanced prostate cancer. Her expertise extends to Lutathera, another innovative radioligand therapy targeting gastroenteropancreatic neuroendocrine tumors (GEP-NET), where she focuses on the markets in Washington and Alaska.
Amy’s extensive background in precision oncology and rare diseases positions her as a key player in the rapidly evolving landscape of radioligand therapies. She has a proven track record of success, consistently achieving EXCEEDS rankings in Management By Objectives (MBOs), which underscores her ability to drive sales effectiveness and deliver results in a competitive environment. Her deep understanding of the pharmaceutical industry, combined with her skills in marketing, product launch, and managed care, allows her to develop and implement strategies that resonate with healthcare providers and improve patient outcomes.
As a true collaborator, Amy excels in training and mentoring sales teams, equipping them with the selling skills necessary to navigate complex therapeutic areas such as urology, neurology, and endocrinology. Her passion for fostering a culture of excellence within her team not only enhances their capabilities but also strengthens the overall impact of Advanced Accelerator Applications in the market. Through her leadership and expertise, Amy continues to contribute to the advancement of innovative therapies that address critical healthcare needs.
